Francisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, Geoffrey Y Ku, Yaelle Tuvy, Helen Won, Christopher J Fong, Nancy Bouvier, Gouri J Nanjangud, Joanne Soong, Efsevia Vakiani, Mark Schattner, David P Kelsen, Robert A Lefkowitz, Karen Brown, Mario E Lacouture, Marinela Capanu, Marissa Mattar, Besnik Qeriqi, Fabiola Cecchi, Yuan Tian, Todd Hembrough, Rebecca J Nagy, Richard B Lanman, Steven M Larson, Neeta Pandit-Taskar, Heiko Schöder, Christine A Iacobuzio-Donahue, David H Ilson, Wolfgang A Weber, Michael F Berger, Elisa de Stanchina, Barry S Taylor, Jason S Lewis, David B Solit, Jorge A Carrasquillo, Maurizio Scaltriti, Nikolaus Schultz, Yelena Y Janjigian. Cancer Discov 2019
Times Cited: 78
Times Cited: 78
Charles S Fuchs, Jiri Tomasek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira Dos Santos, Giuseppe Aprile, David R Ferry, Bohuslav Melichar, Mustapha Tehfe, Eldar Topuzov, John Raymond Zalcberg, Ian Chau, William Campbell, Choondal Sivanandan, Joanna Pikiel, Minori Koshiji, Yanzhi Hsu, Astra M Liepa, Ling Gao, Jonathan D Schwartz, Josep Tabernero. Lancet 2014
Times Cited: 1342
Times Cited: 1342
List of shared articles
Times cited
Progress and challenges in gastroesophageal cancer.
Olbia Serra, Elizabeth C Smyth, Florian Lordick. Curr Probl Cancer 2020
Olbia Serra, Elizabeth C Smyth, Florian Lordick. Curr Probl Cancer 2020
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.
Yoshiaki Nakamura, Akihito Kawazoe, Florian Lordick, Yelena Y Janjigian, Kohei Shitara. Nat Rev Clin Oncol 2021
Yoshiaki Nakamura, Akihito Kawazoe, Florian Lordick, Yelena Y Janjigian, Kohei Shitara. Nat Rev Clin Oncol 2021
Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View.
Justus Körfer, Florian Lordick, Ulrich T Hacker. Cancers (Basel) 2021
Justus Körfer, Florian Lordick, Ulrich T Hacker. Cancers (Basel) 2021
Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.
Ankur K Nagaraja, Osamu Kikuchi, Adam J Bass. Cancer Discov 2019
Ankur K Nagaraja, Osamu Kikuchi, Adam J Bass. Cancer Discov 2019
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.
Surendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, Jochen K Lennerz, Ryan B Corcoran, Rebecca S Heist, Andrea L Russo, Aparna Parikh, Darrell R Borger, Lawrence S Blaszkowsky,[...]. Oncologist 2020
Surendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, Jochen K Lennerz, Ryan B Corcoran, Rebecca S Heist, Andrea L Russo, Aparna Parikh, Darrell R Borger, Lawrence S Blaszkowsky,[...]. Oncologist 2020
Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
Tianfeng Lan, Xia Xue, Louisa Chard Dunmall, Jinxin Miao, Yaohe Wang. Aging (Albany NY) 2021
Tianfeng Lan, Xia Xue, Louisa Chard Dunmall, Jinxin Miao, Yaohe Wang. Aging (Albany NY) 2021
State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer.
Debora Basile, Francesca Simionato, Alessandro Cappetta, Silvio Ken Garattini, Giandomenico Roviello, Giuseppe Aprile. Biologics 2021
Debora Basile, Francesca Simionato, Alessandro Cappetta, Silvio Ken Garattini, Giandomenico Roviello, Giuseppe Aprile. Biologics 2021
Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
Shayan Khalafi, Albert Craig Lockhart, Alan S Livingstone, Wael El-Rifai. Cancers (Basel) 2020
Shayan Khalafi, Albert Craig Lockhart, Alan S Livingstone, Wael El-Rifai. Cancers (Basel) 2020
Next-generation sequencing and biomarkers for gastric cancer: what is the future?
Akihito Kawazoe, Kohei Shitara. Ther Adv Med Oncol 2019
Akihito Kawazoe, Kohei Shitara. Ther Adv Med Oncol 2019